PIN55 Cost-Effectiveness Analysis of Peginterferon Alfa-2A (40KD) in HBEAG-Positive Chronic Hepatitis B in Poland
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.241
https://www.valueinhealthjournal.com/article/S1098-3015(11)01803-1/fulltext
Section Title :
Infection
Section Order :
221
First Page :
A275
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01803-1&doi=10.1016/j.jval.2011.08.241